| Manager | Title | Age | Since |
|---|---|---|---|
Kirk Chin Kee
CEO | Chief Executive Officer | 64 | 14/02/2000 |
Woon Wui Chiew
DFI | Director of Finance/CFO | 52 | 31/12/2023 |
Mei Ling Wong
IRC | Investor Relations Contact | - | 31/12/2008 |
| Director | Title | Age | Since |
|---|---|---|---|
Kirk Chin Kee
CHM | Chairman | 64 | 18/05/2010 |
Robert Millner
BRD | Director/Board Member | 75 | 22/02/2000 |
Kirk Chuen Kee
BRD | Director/Board Member | 61 | 17/05/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/01/26 | Others | Chief Executive Officer | 5,700,000 | 0.7890% | ||
| 07/01/26 | Others | Chief Executive Officer | 4,035,800 | 0.5586% | ||
| 07/01/26 | Others | Chief Executive Officer | 2,979,372 | 0.4124% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 481M | ||
| -2.08% | +0.43% | +29.35% | +112.39% | 106B | ||
| -2.71% | +2.50% | +60.80% | +171.46% | 57.49B | ||
| -0.37% | -0.37% | -11.84% | +262.16% | 22.33B | ||
| +0.12% | +1.97% | -9.60% | -4.72% | 8.23B | ||
| +0.37% | +0.15% | -37.43% | -26.65% | 7.11B | ||
| +0.60% | +3.98% | +5.89% | +31.22% | 6.72B | ||
| +1.26% | +3.42% | -13.63% | -23.67% | 6.3B | ||
| +0.73% | +0.18% | -5.45% | +19.44% | 5.09B | ||
| +2.74% | +12.44% | +346.43% | +523.96% | 4.68B | ||
| Average | +0.07% | +2.60% | +40.50% | +118.40% | 24.87B | |
| Weighted average by Cap. | -1.57% | +2.57% | +33.69% | +134.02% |
Employees
-
Sector
Pharmaceuticals
















